Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ABI-4334 by Assembly Biosciences for Hepatitis B: Likelihood of Approval
ABI-4334 is under clinical development by Assembly Biosciences and currently in Phase I for Hepatitis B. According to GlobalData, Phase...